T. Rowe Price Associates’s Stemline Therapeutics, Inc. STML Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-176,795	Closed	-$1.84M	–	2577
2019 Q3	$1.84M	Sell	176,795 -582,570	-77%	-$7.62M	﹤0.01%	1597
2019 Q2	$11.6M	Sell	759,365 -133,221	-15%	-$1.93M	﹤0.01%	1291
2019 Q1	$11.5M	Buy	+892,586	New	+$10.1M	﹤0.01%	1296
2014 Q4	–	Sell	-54,473	Closed	-$679K	–	2575
2014 Q3	$679K	Sell	54,473 -38,719	-42%	-$477K	﹤0.01%	1830
2014 Q2	$1.37M	Sell	93,192 -737,074	-89%	-$11.3M	﹤0.01%	1652
2014 Q1	$16.9M	Sell	830,266 -46,400	-5%	-$1.13M	﹤0.01%	1159
2013 Q4	$17.2M	Sell	876,666 -47,500	-5%	-$1.27M	﹤0.01%	1140
2013 Q3	$41.9M	Sell	924,166 -6,034	-0.6%	-$197K	0.01%	882
2013 Q2	$22.2M	Buy	+930,200	New	+$14.8M	0.01%	1041